查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941542

临床前影像市场规模、份额和趋势分析报告：按类型、应用、最终用途、地区和细分市场预测（2026-2033 年）

Preclinical Imaging Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

临床前影像市场概述

全球临床前影像市场规模预计到 2025 年将达到 10.5 亿美元，到 2033 年将达到 16.3 亿美元。

预计从 2026 年到 2033 年，该行业将以 5.6% 的复合年增长率成长。这一增长是由慢性病患病率上升、药物研发投资增加以及对非侵入性成像技术的需求增加所驱动的。

早期研究中先进影像技术的应用，以及转化研究工作的不断深入，进一步推动了市场扩张。

政府主导的各项倡议，包括来自美国国立卫生研究院 (NIH) 以及欧洲和亚洲类似机构的津贴和资助，显着加强了临床前研究，并支持了临床前影像市场。例如，2022 年 9 月，NIH 和美国卫生与公众服务部 (DHHS) 发布了针对产肠毒素大肠桿菌 (ETEC)、甲型副伤寒沙门氏菌和志贺氏菌属的里程碑式临床前疫苗开发提案征集。

该计画将在五年内每年提供高达75万美元的资金，用于支持疫苗优化、规模化生产、安全性和有效性测试，以及推进候选疫苗进入临床试验阶段。符合资格的申请对象包括学术机构、非营利组织、政府机构和企业。美国国家过敏症和感染疾病研究所 (NIAID) 将资助四到六个计划，总计520万美元，以加速候选疫苗向美国食品药物管理局 (FDA)津贴临床实验(IND) 申请。这笔资金将使研究人员能够投资于先进平台、开发新型探针并扩展纵向研究，从而满足临床前体内成像市场日益增长的需求，并促进光学临床前成像等领域的发展。

目录

第一章调查方法和范围

第二章执行摘要

3. 临床前影像市场变数、趋势和范围

  • 市场谱系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 临床前影像市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 临床前影像市场：按类型分類的估计和趋势分析

  • 全球临床前影像：按类型分類的市场波动分析
  • 全球临床前影像市场规模及趋势分析（按类型划分）（2021-2033 年）
  • 模态
    • 光学成像（BLI 和 F）
    • 磁振造影（MRI）
    • 正子断层扫描（PET）
    • 单光子发射电脑断层扫描（SPECT）
    • 电脑断层扫描（CT）
    • 超音波影像（US）
    • 光声成像（PAI）
    • 混合成像系统
    • 其他的
  • 试剂
  • 服务

第五章 临床前影像市场：按应用分類的估算与趋势分析

  • 全球临床前影像：按应用分類的市场趋势分析
  • 全球临床前影像市场规模及应用趋势分析（2021-2033）
  • 药物发现与开发
  • 毒理学和药物动力学研究
  • 基础研究与转化研究
  • 疾病机转与病理学研究
    • 肿瘤学
    • 心臟病学
    • 神经病学
    • 感染疾病
    • 免疫学/炎症
    • 其他的
  • 生物标记和诊断成像剂的检验
  • 其他的

第六章：临床前影像市场：依最终用途分類的估算与趋势分析

  • 全球临床前成像：按最终用途分類的市场趋势分析
  • 全球临床前影像市场规模及应用趋势分析（2021-2033）
  • 製药和生物技术公司
  • 受託研究机构（CRO）
  • 学术研究机构
  • 其他的

7. 临床前影像市场：区域估算和趋势分析（按类型、应用和最终用途划分）

  • 区域市场占有率分析（2025 年和 2033 年）
  • 区域市场概览
  • 全球市场概览（按地区划分）
  • 市场规模及预测趋势分析（2021-2033）：
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 对主要市场参与企业近期趋势和影响的分析
  • 公司/竞争对手分类
  • 主要企业市占率分析（2025 年）
  • 公司地位分析
  • 公司分类（新兴企业、创新者、领导企业）
  • 公司简介
    • Cubresa Inc.
    • Bruker Corporation
    • Revvity（PerkinElmer, Inc）
    • FUJIFILM VisualSonics
    • Mediso Ltd.
    • Rigaku（MILabs BV）
    • MR Solutions
    • Aspect Imaging
    • TriFoil Imaging
    • Siemens Healthineers
Product Code: 978-1-68038-881-7

Preclinical Imaging Market Summary

The global preclinical imaging market size was valued at USD 1.05 billion in 2025 and is expected to reach USD 1.63 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. This growth is driven by the rising prevalence of chronic diseases, increasing investments in drug development, and growing demand for non-invasive imaging techniques.

The adoption of advanced imaging modalities for early-stage research, coupled with the expansion of translational research initiatives, further accelerates market expansion.

Government initiatives, including grants and funding from organizations such as the National Institutes of Health (NIH) and similar agencies in Europe and Asia, are significantly enhancing preclinical research and bolstering the preclinical imaging market. For example, in September 2022, the NIH and the U.S. Department of Health and Human Services (DHHS) called for applications for milestone-driven preclinical vaccine development targeting Enterotoxigenic Escherichia coli (ETEC), Salmonella Paratyphi A, and Shigella species.

The program supported vaccine optimization, scale-up, safety, and efficacy testing, offering up to USD 750,000 annually over five years to help candidates reach clinical readiness. Eligible applicants included academic institutions, nonprofits, governments, and businesses. The National Institute of Allergy and Infectious Diseases (NIAID) planned to award USD 5.2 million across 4-6 projects to advance candidates toward FDA IND submission. This influx of funding allows researchers to invest in advanced platforms, develop new probes, and expand longitudinal studies, increasing demand in the preclinical in-vivo imaging market and supporting growth in segments like optical preclinical imaging.

Global Preclinical Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global preclinical imaging market based on type, application, end use and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Modality
    • Optical Imaging (BLI & F)
    • Magnetic Resonance Imaging (MRI)
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
    • Computed Tomography (CT)
    • Ultrasound Imaging (US)
    • Photoacoustic Imaging (PAI)
    • Hybrid Imaging Systems
    • Bi-Modal
    • SPECT-CT
    • PET-CT
    • SPECT-PET
    • PET-MRI
    • Optical-CT
    • Others
    • Tri-Modal
    • PET-SPECT-CT
    • PET-SPECT-MRI
    • PET-CT-Optical
    • Others
    • Others
  • Reagent
  • Service
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Toxicology & Pharmacokinetics Studies
  • Basic & Translational Research
  • Disease Mechanism & Pathophysiology Studies
    • Oncology
    • Cardiology
    • Neurology
    • Infectious Diseases
    • Immunology & Inflammation
    • Others
  • Biomarker & Imaging Agent Validation
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Preclinical Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Preclinical Imaging Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Preclinical Imaging Type Market Movement Analysis
  • 4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Modality
    • 4.4.1. Modality market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Optical Imaging (BLI & F)
      • 4.4.2.1. Optical Imaging (BLI & F) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Magnetic Resonance Imaging (MRI)
      • 4.4.3.1. Magnetic Resonance Imaging (MRI) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Positron Emission Tomography (PET)
      • 4.4.4.1. Positron Emission Tomography (PET) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.5. Single Photon Emission Computed Tomography (SPECT)
      • 4.4.5.1. Single Photon Emission Computed Tomography (SPECT) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.6. Computed Tomography (CT)
      • 4.4.6.1. Computed Tomography (CT) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.7. Ultrasound Imaging (US)
      • 4.4.7.1. Ultrasound Imaging (US) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.8. Photoacoustic Imaging (PAI)
      • 4.4.8.1. Photoacoustic Imaging (PAI) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.9. Hybrid Imaging Systems
      • 4.4.9.1. Hybrid Imaging Systems market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.2. Bi-Modal
        • 4.4.9.2.1. Bi-Modal market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.2. SPECT-CT
          • 4.4.9.2.2.1. SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.3. PET-CT
          • 4.4.9.2.3.1. PET-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.4. SPECT-PET
          • 4.4.9.2.4.1. SPECT-PET market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.5. PET-MRI
          • 4.4.9.2.5.1. PET-MRI market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.6. Optical-CT
          • 4.4.9.2.6.1. Optical-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.2.7. Others
          • 4.4.9.2.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
      • 4.4.9.3. Tri-Modal
        • 4.4.9.3.1. Tri-Modal market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.2. PET-SPECT-CT
          • 4.4.9.3.2.1. PET-SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.3. PET-SPECT-MRI
          • 4.4.9.3.3.1. PET-SPECT-MRI market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.4. PET-CT-Optical
          • 4.4.9.3.4.1. PET-CT-Optical market estimates and forecasts 2021 to 2033 (USD Million)
        • 4.4.9.3.5. Others
          • 4.4.9.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.10. Others
      • 4.4.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Reagent
    • 4.5.1. Reagent market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Preclinical Imaging Application Market Movement Analysis
  • 5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery & Development
    • 5.4.1. Drug Discovery & Development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Toxicology & Pharmacokinetics Studies
    • 5.5.1. Toxicology & Pharmacokinetics Studies market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Basic & Translational Research
    • 5.6.1. Basic & Translational Research market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Disease Mechanism & Pathophysiology Studies
    • 5.7.1. Disease Mechanism & Pathophysiology Studies market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.2. Oncology
      • 5.7.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.3. Cardiology
      • 5.7.3.1. Cardiology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.4. Neurology
      • 5.7.4.1. Neurology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.5. Infectious Diseases
      • 5.7.5.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.6. Immunology & Inflammation
      • 5.7.6.1. Immunology & Inflammation market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.7.7. Others
      • 5.7.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Biomarker & Imaging Agent Validation
    • 5.8.1. Biomarker & Imaging Agent Validation market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Preclinical Imaging End Use Market Movement Analysis
  • 6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharma and Biotech Companies
    • 6.4.1. Pharma and biotech companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Contract Research Organizations (CROs)
    • 6.5.1. Contract Research Organizations (CROs) market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Academic and Research Institutes
    • 6.6.1. Academic and Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Type, Application, End Use

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2025
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders)
  • 8.6. Company Profiles
    • 8.6.1. Cubresa Inc.
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Bruker Corporation
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Revvity (PerkinElmer, Inc)
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. FUJIFILM VisualSonics
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Mediso Ltd.
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Rigaku (MILabs B.V.)
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. MR Solutions
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. Aspect Imaging
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. TriFoil Imaging
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. Siemens Healthineers
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 3 North America preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 4 North America preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 5 North America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 7 U.S. preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 8 U.S. preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 9 Canada preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 10 Canada preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 11 Canada preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 13 Mexico preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 14 Mexico preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 15 Europe preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 16 Europe preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 17 Europe preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 18 Europe preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 19 UK preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 20 UK preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 21 UK preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 22 Germany preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 23 Germany preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 24 Germany preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 25 France preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 26 France preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 27 France preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 28 Italy preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 29 Italy preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 30 Italy preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 31 Denmark preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 32 Denmark preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 33 Denmark preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 34 Sweden preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 35 Sweden preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 36 Sweden preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 37 Norway preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 38 Norway preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 39 Norway preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 40 Asia Pacific preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 42 Asia Pacific preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 44 Japan preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 45 Japan preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 46 Japan preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 47 China preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 48 China preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 49 China preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 50 India preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 51 India preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 52 India preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 53 Australia preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 54 Australia preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 55 Australia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 57 South Korea preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 58 South Korea preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 59 Thailand preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 60 Thailand preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 61 Thailand preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 62 Latin America preclinical imaging market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Latin America preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 64 Latin America preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 65 Latin America preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 66 Brazil preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 67 Brazil preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 68 Brazil preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 69 Argentina preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 70 Argentina preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 71 Argentina preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 72 Middle East & Africa preclinical imaging market, By country, 2021 - 2033 (USD Million)
  • Table 73 Middle East & Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 74 Middle East & Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 75 Middle East & Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 76 South Africa preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 77 South Africa preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 78 South Africa preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 79 Saudi Arabia preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 80 Saudi Arabia preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 81 Saudi Arabia preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 82 UAE preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 83 UAE preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 84 UAE preclinical imaging market, By end use, 2021 - 2033 (USD Million)
  • Table 85 Kuwait preclinical imaging market, By type, 2021 - 2033 (USD Million)
  • Table 86 Kuwait preclinical imaging market, By application, 2021 - 2033 (USD Million)
  • Table 87 Kuwait preclinical imaging market, By end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Preclinical imaging market: Market outlook
  • Fig. 14 Preclinical imaging market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Preclinical imaging market driver impact
  • Fig. 20 Preclinical imaging restraint impact
  • Fig. 21 Preclinical imaging market: type movement analysis
  • Fig. 22 Preclinical imaging market: type outlook and key takeaways
  • Fig. 23 Modality market estimates and forecast, 2021 - 2033
  • Fig. 24 Optical Imaging (BLI & F) market estimates and forecast, 2021 - 2033
  • Fig. 25 MRI market estimates and forecast, 2021 - 2033
  • Fig. 26 PET market estimates and forecast, 2021 - 2033
  • Fig. 27 SPECT market estimates and forecast, 2021 - 2033
  • Fig. 28 CT market estimates and forecast, 2021 - 2033
  • Fig. 29 Ultrasound Imaging (US) market estimates and forecast, 2021 - 2033
  • Fig. 30 Photoacoustic Imaging (PAI) market estimates and forecast, 2021 - 2033
  • Fig. 31 Hybrid Imaging Systems market estimates and forecast, 2021 - 2033
  • Fig. 32 Bi-Modal market estimates and forecast, 2021 - 2033
  • Fig. 33 SPECT-CT market estimates and forecast, 2021 - 2033
  • Fig. 34 PET-CT market estimates and forecast, 2021 - 2033
  • Fig. 35 SPECT-PET market estimates and forecast, 2021 - 2033
  • Fig. 36 PET-MRI market estimates and forecast, 2021 - 2033
  • Fig. 37 Optical-CT market estimates and forecast, 2021 - 2033
  • Fig. 38 Others market estimates and forecast, 2021 - 2033
  • Fig. 39 Tri-Modal market estimates and forecast, 2021 - 2033
  • Fig. 40 PET-SPECT-CT market estimates and forecast, 2021 - 2033
  • Fig. 41 PET-SPECT-MRI market estimates and forecast, 2021 - 2033
  • Fig. 42 PET-CT-Optical market estimates and forecast, 2021 - 2033
  • Fig. 43 Others market estimates and forecast, 2021 - 2033
  • Fig. 44 Reagents market estimates and forecast, 2021 - 2033
  • Fig. 45 Services market estimates and forecast, 2021 - 2033
  • Fig. 46 Preclinical imaging market: application movement analysis
  • Fig. 47 Preclinical imaging market: application outlook and key takeaways
  • Fig. 48 Drug Discovery & Development market estimates and forecast, 2021 - 2033
  • Fig. 49 Toxicology & Pharmacokinetics Studies market estimates and forecast, 2021 - 2033
  • Fig. 50 Basic & Translational Research market estimates and forecast, 2021 - 2033
  • Fig. 51 Disease Mechanism & Pathophysiology Studies market estimates and forecast, 2021 - 2033
  • Fig. 52 Oncology market estimates and forecast, 2021 - 2033
  • Fig. 53 Cardiology market estimates and forecast, 2021 - 2033
  • Fig. 54 Neurology market estimates and forecast, 2021 - 2033
  • Fig. 55 Infectious Diseases market estimates and forecast, 2021 - 2033
  • Fig. 56 Immunology & Inflammation market estimates and forecast, 2021 - 2033
  • Fig. 57 Others market estimates and forecast, 2021 - 2033
  • Fig. 58 Biomarker & Imaging Agent Validation market estimates and forecast, 2021 - 2033
  • Fig. 59 Others market estimates and forecast, 2021 - 2033
  • Fig. 60 Preclinical imaging market: end use movement analysis
  • Fig. 61 Preclinical imaging market: end use outlook and key takeaways
  • Fig. 62 Pharma and biotech companies market estimates and forecast, 2021 - 2033
  • Fig. 63 Contract Research Organizations (CROs) market estimates and forecast, 2021 - 2033
  • Fig. 64 Academic and Research Institutes market estimates and forecast, 2021 - 2033
  • Fig. 65 Others market estimates and forecast, 2021 - 2033
  • Fig. 66 Global Preclinical Imaging Market: regional movement analysis
  • Fig. 67 Global Preclinical Imaging Market: regional outlook and key takeaways
  • Fig. 68 North America
  • Fig. 69 North America market estimates and forecast, 2021 - 2033
  • Fig. 70 U.S.
  • Fig. 71 U.S. market estimates and forecast, 2021 - 2033
  • Fig. 72 Canada
  • Fig. 73 Canada market estimates and forecast, 2021 - 2033
  • Fig. 74 Mexico
  • Fig. 75 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 76 Europe
  • Fig. 77 Europe. market estimates and forecast, 2021 - 2033
  • Fig. 78 UK
  • Fig. 79 UK market estimates and forecast, 2021 - 2033
  • Fig. 80 Germany
  • Fig. 81 Germany market estimates and forecast, 2021 - 2033
  • Fig. 82 France
  • Fig. 83 France market estimates and forecast, 2021 - 2033
  • Fig. 84 Italy
  • Fig. 85 Italy market estimates and forecast, 2021 - 2033
  • Fig. 86 Spain
  • Fig. 87 Spain market estimates and forecast, 2021 - 2033
  • Fig. 88 Denmark
  • Fig. 89 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 90 Sweden
  • Fig. 91 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 92 Norway
  • Fig. 93 Norway market estimates and forecast, 2021 - 2033
  • Fig. 94 Asia Pacific
  • Fig. 95 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 96 Japan
  • Fig. 97 Japan market estimates and forecast, 2021 - 2033
  • Fig. 98 China
  • Fig. 99 China market estimates and forecast, 2021 - 2033
  • Fig. 100 India
  • Fig. 101 India market estimates and forecast, 2021 - 2033
  • Fig. 102 South Korea
  • Fig. 103 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 104 Thailand
  • Fig. 105 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 106 Australia
  • Fig. 107 Australia market estimates and forecast, 2021 - 2033
  • Fig. 108 Latin America
  • Fig. 109 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 110 Brazil
  • Fig. 111 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 112 Argentina
  • Fig. 113 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 114 Middle East and Africa
  • Fig. 115 Middle East and Africa. market estimates and forecast, 2021 - 2033
  • Fig. 116 Saudi Arabia
  • Fig. 117 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 118 South Africa
  • Fig. 119 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 120 UAE
  • Fig. 121 UAE market estimates and forecast, 2021 - 2033
  • Fig. 122 Kuwait
  • Fig. 123 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 124 Participant categorization- Preclinical imaging market
  • Fig. 125 Market share of key market players- Preclinical imaging market